主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Liao Qianli1 Fan Xiaochun23
单位:1四川大学华西医院全科(特需)病房,成都610041;2四川省南充市中医医院筋骨病中医药防治南充市重点实验室,南充637000;3川北医学院医学影像四川省重点实验室,南充637000
英文单位:1General (Special needs) Ward West China Hospital Sichuan University Chengdu 610041 China; 2Nanchong Key Laboratory of TCM Prevention and Treatment of Muscle and Bone Diseases Nanchong Hospital of Traditional Chinese Medicine Sichuan Province Nanchong 637000 China; 3Sichuan Provincial Key Laboratory of Medical Imaging North Sichuan Medical College Nanchong 637000 China
英文关键词:Hypertension;Heartfailure;First-lineantihypertensivedrugs;Ejectionfraction
降压药物治疗是伴发心力衰竭的高血压患者重要干预手段,血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂、血管紧张素受体脑啡肽酶抑制剂、利尿剂、钙通道阻滞剂及β受体阻滞剂是临床目前常用一线降压药物。对于高血压合并心力衰竭这类高危患者,临床普遍采取多种药物联合治疗方案,且不同左心室射血分数分级患者降压药物疗效存在差异,因此,使用降压药物前对高血压患者心血管病变情况进行分层将有利于指导临床进行合理用药。本文就最新一线降压药物对于高血压合并心力衰竭的治疗效果及研究进展进行综述。
Antihypertensive drug therapy is an important intervention for hypertensive patients with heart failure. Angiotensin converting enzyme inhibitor, angiotensin Ⅱ receptor blocker, angiotensin receptor neprilysin inhibitor, diuretic, calcium channel blocker and β-receptor blocker are commonly used as first-line antihypertensive drugs in clinical practice. For high-risk patients with hypertension and heart failure, multi-drug combination therapy is generally adopted in clinical practice, and the efficacy of antihypertensive drugs is different in patients with different left ventricular ejection fraction grades. Therefore, the stratification of cardiovascular disease in hypertensive patients before the use of antihypertensive drugs will be helpful to guide clinical rational drug use. This article reviews the therapeutic effect and research progress of the latest first-line antihypertensive drugs for hypertension complicated with heart failure.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。